Ascendis Pharma (ASND) earnings per share (EPS)

Earnings per share · fiscal 2025
-€3.76

Ascendis Pharma (ASND) reported diluted earnings per share of -€3.76 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -€6.53. Figures as of 17 Nov 2026, 19:05 UTC, from Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
-€3.76
Highest on record
-€3.76fiscal 2025
Lowest on record
-€10.40fiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in EUR. Figures, not advice.

Ascendis Pharma earnings per share (EPS), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was -€3.76 in fiscal 2025 and the lowest -€10.40 in fiscal 2022.

History · 4 fiscal years

Earnings per share by fiscal year

Ascendis Pharma earnings per share (EPS), year by year

Ascendis Pharma (ASND) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025-€3.76—
2024-€6.53—
2023-€8.55—
2022-€10.40—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Ascendis Pharma and comparable companies
CompanyEarnings per shareFiscal year
Revvity RVTY$2.072025
Exelixis EXEL$2.782025
Charles River Laboratories International CRL-$2.912025
Neurocrine Biosciences NBIX$4.672025
Ascendis Pharma ASND-€3.762025
ICON ICLR$2.712025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ASND

Ascendis Pharma, figure by figure

Ascendis Pharma (ASND) overview: price, valuation and scorecardAll health care companies by market value

Ascendis Pharma earnings per share (EPS): questions and answers

What is Ascendis Pharma's diluted earnings per share?

Ascendis Pharma (ASND) reported diluted earnings per share of -€3.76 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -€6.53.

What are the highest and lowest diluted earnings per share figures on record for Ascendis Pharma?

Across the 4 fiscal years on record (2022–2025), the highest was -€3.76 in fiscal 2025 and the lowest -€10.40 in fiscal 2022.

How is Ascendis Pharma's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ascendis Pharma (ASND) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/ASND/eps

Underlying data: Yahoo Finance.